Total Payments
$12,118
2024 Payments
$2,639
Companies
37
Transactions
801
Medicare Patients
515
Medicare Billing
$111,324
Payment Breakdown by Category
Food & Beverage$12,004 (99.1%)
Education$113.74 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,004 | 795 | 99.1% |
| Education | $113.74 | 6 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $1,465 | 131 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,255 | 65 | $0 (2020) |
| Shire North American Group Inc | $901.96 | 72 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $698.05 | 62 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $586.05 | 38 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $576.14 | 41 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $575.45 | 30 | $0 (2024) |
| ABBVIE INC. | $503.74 | 21 | $0 (2024) |
| Neos Therapeutics, LP | $492.08 | 33 | $0 (2024) |
| Allergan, Inc. | $484.13 | 31 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,639 | 138 | Supernus Pharmaceuticals, Inc. ($289.73) |
| 2023 | $2,520 | 141 | Teva Pharmaceuticals USA, Inc. ($367.40) |
| 2022 | $293.14 | 18 | Supernus Pharmaceuticals, Inc. ($125.85) |
| 2020 | $382.54 | 25 | Sunovion Pharmaceuticals Inc. ($75.66) |
| 2019 | $2,262 | 164 | Sunovion Pharmaceuticals Inc. ($385.73) |
| 2018 | $2,007 | 159 | Lundbeck LLC ($355.37) |
| 2017 | $2,014 | 156 | Sunovion Pharmaceuticals Inc. ($448.67) |
All Payment Transactions
801 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Tris Pharma Inc | — | Food and Beverage | In-kind items and services | $24.33 | General |
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $13.80 | General |
| 10/31/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: CNS | ||||||
| 10/31/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/29/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $18.86 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: Neuropsychiatry | ||||||
| 10/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $12.22 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Neuropsychiatry | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/30/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Neuroscience | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Neuropsychiatry | ||||||
| 09/08/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 110 | 433 | $81,329 | $22,671 |
| 2022 | 1 | 122 | 559 | $100,173 | $29,929 |
| 2021 | 1 | 128 | 574 | $98,651 | $31,859 |
| 2020 | 2 | 155 | 623 | $104,590 | $26,866 |
Total Patients
515
Total Services
2,189
Medicare Billing
$111,324
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 433 | $81,329 | $22,671 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 122 | 559 | $100,173 | $29,929 | 29.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 128 | 574 | $98,651 | $31,859 | 32.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 143 | 611 | $102,562 | $26,261 | 25.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 12 | 12 | $2,028 | $604.14 | 29.8% |
About Dr. Robert Callaghan, M.D
Dr. Robert Callaghan, M.D is a Child & Adolescent Psychiatry healthcare provider based in Sturtevant, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275520033.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Callaghan, M.D has received a total of $12,118 in payments from pharmaceutical and medical device companies, with $2,639 received in 2024. These payments were reported across 801 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($12,004).
As a Medicare-enrolled provider, Callaghan has provided services to 515 Medicare beneficiaries, totaling 2,189 services with total Medicare billing of $111,324. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry
- Location Sturtevant, WI
- Active Since 10/05/2005
- Last Updated 05/22/2018
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1275520033
Products in Payments
- LATUDA (Drug) $1,255
- REXULTI (Drug) $1,220
- VRAYLAR (Drug) $939.35
- VYVANSE (Drug) $666.45
- Adzenys XR-ODT (Drug) $492.08
- TRINTELLIX (Drug) $490.96
- ABILIFY MAINTENA (Drug) $460.04
- Trintellix (Drug) $414.53
- Azstarys (Drug) $353.70
- INGREZZA (Drug) $344.81
- ARISTADA (Drug) $313.23
- INVEGA SUSTENNA (Drug) $307.96
- CAPLYTA (Drug) $300.17
- Qelbree (Drug) $289.73
- QELBREE (Drug) $285.72
- Auvelity (Drug) $284.45
- MYDAYIS (Drug) $279.19
- SPRAVATO (Drug) $278.09
- Aptensio XR (Drug) $257.76
- Austedo XR (Drug) $245.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.